These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2904376)

  • 1. Kynurenic acid and AP5 distinguish between NMDA receptor agonists.
    Williams TL; Stone TW; Burton NR; Smith DA
    Exp Neurol; 1988 Dec; 102(3):366-7. PubMed ID: 2904376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro.
    Burton NR; Smith DA; Stone TW
    Br J Pharmacol; 1988 Mar; 93(3):693-701. PubMed ID: 2897220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
    Ganong AH; Cotman CW
    J Pharmacol Exp Ther; 1986 Jan; 236(1):293-9. PubMed ID: 2867215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid pharmacology in neocortical slices: evidence for bimolecular actions from an extension of the Hill and Gaddum-Schild equations.
    Williams TL; Smith DA; Burton NR; Stone TW
    Br J Pharmacol; 1988 Nov; 95(3):805-10. PubMed ID: 2905185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique.
    Mayer ML; Westbrook GL; Vyklický L
    J Neurophysiol; 1988 Aug; 60(2):645-63. PubMed ID: 2902200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat.
    Winn P; Stone TW; Latimer M; Hastings MH; Clark AJ
    Br J Pharmacol; 1991 Apr; 102(4):904-8. PubMed ID: 1677299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of ictal-like activity by kynurenic acid does not correlate with its efficacy as an NMDA receptor antagonist.
    Brady RJ; Swann JW
    Epilepsy Res; 1988; 2(4):232-8. PubMed ID: 2904365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+-dependent depolarization and burst firing of rat CA1 pyramidal neurones induced by N-methyl-D-aspartic acid and quinolinic acid: antagonism by 2-amino-5-phosphonovaleric and kynurenic acids.
    Peet MJ; Curry K; Magnuson DS; McLennan H
    Can J Physiol Pharmacol; 1986 Feb; 64(2):163-8. PubMed ID: 2870788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative potencies of (-)-2-amino-5-phosphonovalerate and (-)-2-amino-7-phosphonoheptanoate as antagonists of N-methylaspartate and quinolinic acids and repetitive spikes in rat hippocampal slices.
    Stone TW
    Brain Res; 1986 Aug; 381(1):195-8. PubMed ID: 2875764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of N-methyl-D-aspartate and quinolinate on central neurones of the rat.
    McLennan H
    Neurosci Lett; 1984 May; 46(2):157-60. PubMed ID: 6146117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effect of quinolinate on frog spinal, but not rat cortical, neurones: N-methyl-D-aspartate-like depolarisation and a novel type of hyperpolarisation.
    Martin D; Lodge D
    Neurosci Lett; 1987 Mar; 75(2):175-80. PubMed ID: 2883613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo release of [3H]-purines by quinolinic acid and related compounds.
    Perkins MN; Stone TW
    Br J Pharmacol; 1983 Oct; 80(2):263-7. PubMed ID: 6317129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
    Foster AC; Gill R; Woodruff GN
    J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors.
    Birch PJ; Grossman CJ; Hayes AG
    Eur J Pharmacol; 1988 Jul; 151(2):313-5. PubMed ID: 2901972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
    Verdoorn TA; Dingledine R
    Mol Pharmacol; 1988 Sep; 34(3):298-307. PubMed ID: 2901662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketamine on the in vivo toxicity of quinolinate and N-methyl-D-aspartate in the rat hippocampus.
    Lees GJ
    Neurosci Lett; 1987 Jul; 78(2):180-6. PubMed ID: 2888058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinate is a weak excitant of cortical neurons in cell culture.
    Peters S; Choi DW
    Brain Res; 1987 Sep; 420(1):1-10. PubMed ID: 2890410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo.
    Perkins MN; Stone TW
    Exp Neurol; 1985 Jun; 88(3):570-9. PubMed ID: 2987017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate.
    Raigorodsky G; Urca G
    Eur J Pharmacol; 1990 Jun; 182(1):37-47. PubMed ID: 1976097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors.
    Salt TE
    Nature; 1986 Jul 17-23; 322(6076):263-5. PubMed ID: 2874492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.